An examination of IC50 and IC50-shift experiments in assessing time-dependent inhibition of CYP3A4, CYP2D6 and CYP2C9 in human liver microsomes
- PMID: 19356071
- DOI: 10.2174/187231208783478407
An examination of IC50 and IC50-shift experiments in assessing time-dependent inhibition of CYP3A4, CYP2D6 and CYP2C9 in human liver microsomes
Abstract
The relationship between time-dependent inactivation (TDI) and IC50 is examined using a consolidated method for evaluating CYP450 inhibition during drug discovery. An IC50 fold-shift of >1.5 indicated significant TDI potency. Further, the "shifted IC50" could be used to estimate, the K(I) and TDI potency ratio k(inact)/K(I) to within 2-fold in most cases.
Similar articles
-
Time-dependent inhibition (TDI) of CYP3A4 and CYP2C9 by noscapine potentially explains clinical noscapine-warfarin interaction.Br J Clin Pharmacol. 2010 Feb;69(2):193-9. doi: 10.1111/j.1365-2125.2009.03572.x. Br J Clin Pharmacol. 2010. PMID: 20233183 Free PMC article.
-
Automated screening with confirmation of mechanism-based inactivation of CYP3A4, CYP2C9, CYP2C19, CYP2D6, and CYP1A2 in pooled human liver microsomes.Drug Metab Dispos. 2005 Aug;33(8):1211-9. doi: 10.1124/dmd.104.003475. Epub 2005 Apr 28. Drug Metab Dispos. 2005. PMID: 15860655
-
Inhibitory effects of gypenosides on seven human cytochrome P450 enzymes in vitro.Food Chem Toxicol. 2013 Jul;57:262-5. doi: 10.1016/j.fct.2013.03.041. Epub 2013 Apr 9. Food Chem Toxicol. 2013. PMID: 23583485
-
In vitro modulatory effects on three major human cytochrome P450 enzymes by multiple active constituents and extracts of Centella asiatica.J Ethnopharmacol. 2010 Jul 20;130(2):275-83. doi: 10.1016/j.jep.2010.05.002. Epub 2010 May 8. J Ethnopharmacol. 2010. PMID: 20457244
-
The inhibitory effects of herbal components on CYP2C9 and CYP3A4 catalytic activities in human liver microsomes.Am J Ther. 2004 May-Jun;11(3):206-12. doi: 10.1097/00045391-200405000-00009. Am J Ther. 2004. PMID: 15133536 Review.
Cited by
-
Inhibitory Mechanisms of Lekethromycin in Dog Liver Cytochrome P450 Enzymes Based on UPLC-MS/MS Cocktail Method.Molecules. 2023 Oct 20;28(20):7193. doi: 10.3390/molecules28207193. Molecules. 2023. PMID: 37894672 Free PMC article.
-
Consideration of Nevirapine Analogs To Reduce Metabolically Linked Hepatotoxicity: A Cautionary Tale of the Deuteration Approach.Chem Res Toxicol. 2023 Sep 28;36(10):1631-42. doi: 10.1021/acs.chemrestox.3c00192. Online ahead of print. Chem Res Toxicol. 2023. PMID: 37769118
-
In vitro metabolic characterization of the SARS-CoV-2 papain-like protease inhibitors GRL0617 and HY-17542.Front Pharmacol. 2023 Feb 15;14:1067408. doi: 10.3389/fphar.2023.1067408. eCollection 2023. Front Pharmacol. 2023. PMID: 36874001 Free PMC article.
-
In vitro and In silico studies of interactions of cathinone with human recombinant cytochrome P450 CYP(1A2), CYP2A6, CYP2B6, CYP2C8, CYP2C19, CYP2E1, CYP2J2, and CYP3A5.Toxicol Rep. 2022 Mar 30;9:759-768. doi: 10.1016/j.toxrep.2022.03.040. eCollection 2022. Toxicol Rep. 2022. PMID: 36518400 Free PMC article.
-
Protein-Ligand Identification and In Vitro Inhibitory Effects of Cathine on 11 Major Human Drug Metabolizing Cytochrome P450s.Int J Toxicol. 2022 Sep-Oct;41(5):355-366. doi: 10.1177/10915818221103790. Epub 2022 Jun 4. Int J Toxicol. 2022. PMID: 35658727 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources